Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

Nucleic Acids Research

Volumn 34, Issue 1, 2006, Pages 322-333

  Bartlett, Derek W ^a   Davis, Mark E ^a  

^a California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; FIREFLY LUCIFERASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL DIVISION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; ENZYME KINETICS; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PLASMID; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; RNA METABOLISM; RNA STABILITY; RNA TRANSLATION; SUBCUTANEOUS TISSUE TUMOR;

ANIMALS; CELL LINE; CELL PROLIFERATION; HEPATOCYTES; KINETICS; LUCIFERASES, FIREFLY; LUMINESCENT AGENTS; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

ANIMALIA;

EID: 31544456413     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkj439     Document Type: Article

References (55)

1. Fire,A., Xu,S., Montgomery,M.K., Kostas,S.A., Driver,S.E. and Mello,C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
2. Medema,R.H. (2004) Optimizing RNA interference for application in mammalian cells. Biochem. J., 380, 593-603.
3. Mittal,V. (2004) Improving the efficiency of RNA interference in mammals. Nature Rev. Genet., 5, 355-365.
4. Sioud,M. (2005) On the delivery of small interfering RNAs into mammalian cells. Expert Opin. Drug Deliv., 2, 639-651.
5. Ryther,R., Flynt,A., Phillips,J.,III and Patton,J. (2005) siRNA therapeutics: Big potential from small RNAs. Gene Ther., 12, 5-11.
6. Hannon,G.J. and Rossi,J.J. (2004) Unlocking the potential of the human genome with RNA interference. Nature, 431, 371-378.
7. Dorsett,Y. and Tuschi,T. (2004) siRNAs: Applications in functional genomics and potential as therapeutics. Nature Rev. Drug Discov., 3, 318-329.
8. Caplen,N.J. and Mousses,S. (2003) Short interfering RNA (siRNA)-mediated RNA interference (RNAi) in human cells. Ann. NY Acad. Sci., 1002, 56-62.
9. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498.
10. Scherer,L.J. and Rossi,J.J. (2003) Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol., 21, 1457-1465.
11. Stark,G.R., Kerr,I.M., Williams,B.R.G., Silverman,R.H. and Schreiber,R.D. (1998) How cells respond to interferons. Annu. Rev. Biochem., 67, 227-264.
12. Overhoff,M., Wunsche,W. and Sczakiel,G. (2004) Quantitative detection of siRNA and single-stranded oligonucleotides: Relationship between uptake and biological activity of siRNA. Nucleic Acids Res., 32, e170.
13. Lingor,P., Michel,U., Scholl,U., Bahr,M. and Kugler,S. (2004) Transfection of 'naked' siRNA results in endosomal uptake and metabolic impairment in cultured neurons. Biochem: Biophys. Res. Commun., 315, 1126-1133.
14. Hu-Lieskovan,S., Heidel,J.D., Bartlett,D.W., Davis,M.E. and Triche,T.J. (2005) Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of Ewing's sarcoma. Cancer Res., 65, 8984-8992.
15. Bergstrom,C.T., McKittrick,E. and Antia,R. (2003) Mathematical models of RNA silencing: Unidirectional amplification limits accidental self-directed reactions. Proc. Natl Acad. Sci. USA, 100, 11511-11516.
16. Groenenboom,M.A.C., Maree,A.F.M. and Hogeweg,P. (2005) The RNA silencing pathway: The bits and pieces that matter. PLoS Comput. Biol., 1, 155-165.
17. Raab,R.M. and Stephanopoulos,G. (2004) Dynamics of gene silencing by RNA interference. Biotechnol. Bioeng., 88, 121-132.
18. Arciero,J.C., Jackson,T.L. and Kirschner,D.E. (2004) A mathematical model of tumor-immune evasion and siRNA treatment. Discrete and Continuous Dynamical Systems, 4, 39-58.
19. Bahner,I., Kearns,K., Hao,Q., Smogorzewska,E. and Kohn,D. (1996) Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J. Virol., 70, 4352-4360.
20. Challita,P.-M., Skelton,D., El-Khoueiry,A., Yu,X.-J., Weinberg,K. and Kohn,D.B. (1995) Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol., 69, 748-755.
21. Davis,M.E., Pun,S.H., Bellocq,N.C., Reineke,T.M., Popielarski,S.R., Mishra,S. and Heidel,J.D. (2004) Self-assembling nucleic acid delivery vehicles via linear, water-soluble cyclodextrin-containing polymers. Curr. Med. Chem., 11, 1241-1253.
22. Pun,S.H. and Davis,M.E. (2002) Development of a nonviral gene delivery vehicle for systemic application. Bioconjug. Chem., 13, 630-639.
23. Kobayashi,N., Nishikawa,M., Hirata,K. and Takakura,Y. (2004) Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: Implication of a nonspecific process in efficient intracellular gene delivery. J. Gene. Med., 6, 584-592.
24. Andrianaivo,F., Lecocq,M., Wattiaux-De Coninck,S., Wattiaux,R. and Jadot,M. (2004) Hydrodynamics-based transfection of the liver: Entrance into hepatocytes of DNA that causes expression takes place very early after injection. J. Gene. Med., 6, 877-883.
25. Ignowski,J.M. and Schaffer,D.V. (2004) Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol. Bioeng., 86, 827-834.
26. Sweeney,T.J., Mailander,V., Tucker,A.A., Olomu,A.B., Zhang,W., Cao,Y-a., Negrin,R.S. and Contag,C.H. (1999) Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl Acad. Sci. USA, 96, 12044-12049.
27. Novina,C.D., Muray,M.F., Dykxhoorn,D.M., Beresford,P.J., Riess,J., Lee,S.-K., Collman,R.G., Lieberman,J., Shankar,P. and Sharp,P.A. (2002) siRNA-directed inhibition of HIV-1 infection. Nature Med., 8, 681-686.
28. Tuschl,T. (2002) Expanding small RNA interference. Nat. Biotechnol., 20, 446-448.
29. Song,E., Lee,S.-K., Dykxhoorn,D.M., Novina,C., Zhang,D., Crawford,K., Cerny,J., Sharp,P.A., Lieberman,J., Manjunath,N. et al. (2003) Sustained small interfering RNA-mediated human immunodeficiency virus type I inhibition in primary macrophages. J. Virol., 77, 7174-7181.
30. Omi,K., Tokunaga,K. and Hohjoh,H. (2004) Long-lasting RNAi activity in mammalian neurons. FEBS Lett., 558, 89-95.
31. Schibler,U. (2003) Circadian rhythms: Liver regeneration clocks on. Science, 302, 234-235.
32. Bertrand,J.-R., Pottier,M., Vekris,A., Opolon,P., Maksimenko,A. and Malvy,C. (2002) Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun., 296, 1000-1004.
33. Layzer,J.M., McCaffrey,A.P., Tanner,A.K., Huang,Z., Kay,M.A. and Sullenger,B.A. (2004) In vivo activity of nuclease-resistant siRNAs. RNA, 10, 766-771.
34. Elmén,J., Thonberg,H., Ljungberg,K., Frieden,M., Westergaard,M., Xu,Y., Wahren,B., Liang,Z., Ørum,H., Koch,T. et al. (2005) Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res., 33, 439-447.
35. Tiscornia,G., Singer,O., Ikawa,M. and Verma,I.M. (2003) A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl Acad. Sci. USA, 100, 1844-1848.
36. Rubinson,D.A., Dillon,C.P., Kwiatkowski,A.V., Sievers,C., Yang,L., Kopinja,J., Zhang,M., McManus,M.T., Gertler,F.B., Scott,M.L. et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice, by RNA interference. Nature Genet., 33, 401-406.
37. Bertrand,J.-R., Pottier,M., Vekris,A., Opolon,P., Maksimenko,A. and Malvy,C. (2002) Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun., 296, 1000-1004.
38. Varga,C., Tedford,N., Thomas,M., Klibanov,A., Griffith,L. and Lauffenburger,D. (2005) Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther., 12, 1023-1032.
39. Roth,C.M. (2005) Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides. Biophys. J., 89, 2286-2295.
40. Kumaran,V., Benten,D., Follenzi,A., Joseph,B., Sarkar,R. and Gupta,S. (2005) Transplantation of endothelial cells corrects the phenotype in hemophilia A mice. J. Thromb. Haemost., 3, 2022-2031.
41. Rajvanshi,P., Kerr,A., Bhargava,K., Burk,R.D. and Gupta,S. (1996) Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: Cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule. Hepatology, 23, 482-496.
42. Martinez,J. and Tuschl,T. (2004) RISC is a 5′ phosphomonoester-producing RNA endonuclease. Genes Dev., 18, 975-980.
43. Haley,B. and Zamore,P.D. (2004) Kinetic analysis of the RNAi enzyme complex. Nature Struct. Mol. Biol., 11, 599-606.
44. Brown,K.M., Chu,C.-y. and Rana,T.M. (2005) Target accessibility dictates the potency of human RISC. Nature Struct. Mol. Biol., 12, 469-470.
45. Krol,A., Maresca,J., Dewhirst,M.W. and Yuan,F. (1999) Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery. Cancer Res., 59, 4136-4141.
46. Pathak,A.P., Artemov,D., Ward,B.D., Jackson,D.G., Neeman,M. and Bhujwalla,Z.M. (2005) Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. Cancer Res., 65, 1425-1432.
47. Chiu,D.T. and Zare,R.N. (1998) Assaying for peptides in individual Aplysia neurons with mass spectrometry. Proc. Natl Acad. Sci. USA, 95, 3338-3340.
48. Hoff,J. (2000) Methods of Blood Collection in the Mouse. Lab Animal, 29, 47-53.
49. Chiu,Y.-L. and Rana,T.M. (2003) siRNA function in RNAi: A chemical modification analysis. RNA, 9, 1034-1048.
50. Alberts,B., Johnson,A., Lewis,J., Raff,M., Roberts,K. and Walter,P. (2002) Molecular Biology of the Cell, 4 edn. Garland Science, NY.
51. Stryer,L. (1995) Biochemistry, 4 edn. W. H. Freeman and Company, NY.
52. Velculescu,V.E., Madden,S.L., Zhang,L., Lash,A.E., Yu,J., Rago,C., Lal,A., Wang,C.J., Beaudry,G.A., Ciriello,K.M. et al. (1999) Analysis of human transcriptomes. Nature Genet., 23, 387-388.
53. Godfrey,T.E., Kim,S.-H., Chavira,M.; Ruff,D.W., Waren,R.S., Gray,J.W. and Jensen,R.H. (2000) Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction. J. Mol. Diagn., 2, 84-91.
54. Varga,C.M., Hong,K. and Lauffenburger,D.A. (2001) Quantitative analysis of synthetic gene delivery vector design properties. Mol. Ther., 4, 438-446.
55. Banks,G.A., Roselli,R.J., Chen,R. and Giorgio,T.D. (2003) A model for the analysis of nonviral gene therapy. Gene Ther., 10, 1766-1775.